Suppr超能文献

囊性纤维化患者的胸部物理治疗:采用鼻压力支持通气可提高耐受性。

Chest physiotherapy in cystic fibrosis: improved tolerance with nasal pressure support ventilation.

作者信息

Fauroux B, Boulé M, Lofaso F, Zérah F, Clément A, Harf A, Isabey D

机构信息

Service de Pneumologie Pédiatrique, Hôpital Armand Trousseau, Paris, France.

出版信息

Pediatrics. 1999 Mar;103(3):E32. doi: 10.1542/peds.103.3.e32.

Abstract

OBJECTIVE

Chest physiotherapy (CPT) is an integral part of the treatment of patients with cystic fibrosis (CF). CPT imposes additional respiratory work that may carry a risk of respiratory muscle fatigue. Inspiratory pressure support ventilation (PSV) is a new mode of ventilatory assistance designed to maintain a constant preset positive airway pressure during spontaneous inspiration with the goal of decreasing the patient's inspiratory work. The aim of our study was 1) to evaluate respiratory muscle fatigue and oxygen desaturation during CPT and 2) to determine whether noninvasive PSV can relieve these potential adverse effects of CPT.

METHODS

Sixteen CF patients in stable condition with a mean age of 13 +/- 4 years participated to the study. For CPT, we used the forced expiratory technique (FET), which consisted of one or more slow active expirations starting near the total lung capacity (TLC) and ending near the residual volume. After each expiration, the child was asked to perform a slow, nonmaximal, diaphragmatic inspiration. After one to four forced breathing cycles, the child was asked to cough and to expectorate. A typical 20-minute CPT session consisted of 10 to 15 FET maneuvers separated by rest periods of 10 to 20 breathing cycles each. During the study, each patient received two CPT sessions in random order on two different days, at the same time of day, with the same physiotherapist. During one of these two sessions, PSV was provided throughout the session (PSV session) via a nasal mask using the pressure support generator ARM25 designed for acute patients (TAEMA, Antony, France). The control session was performed with no nasal mask or PSV. Both CPT sessions were performed without supplemental oxygen. Lung function and maximal inspiratory pressures (PImax) and expiratory pressures (PEmax) were recorded before and after each CPT session.

RESULTS

Mean lung function parameters were comparable before the PSV and the control sessions. Baseline pulse oximetry (SpO2) was significantly correlated with the baseline vital capacity (% predicted) and forced expiratory volume in 1 second (FEV1) (% predicted). PSV was associated with an increase in tidal volume (Vt) from 0.42 +/- 0.01 liters to 1.0 +/- 0.02 liters. Respiratory rate was significantly lower during PSV. SpO2 between the FET maneuvers was significantly higher during PSV as compared with the control session. SpO2 decreases after FET were significantly larger during the control session (nadir: 91.8 +/- 0. 7%) than during the PSV session (93.8 +/- 0.6%). Maximal pressures decreased during the control session (from 71.9 +/- 6.1 to 60.9 +/- 5.3 cmH2O, and from 85.3 +/- 7.9 to 77.5 +/- 4.8 cmH2O, for PImax and PEmax, respectively) and increased during the PSV session (from 71.6 +/- 8.6 to 83.9 +/- 8.7 cmH2O, and from 80.4 +/- 7.8 to 88.0 +/- 7.4 cmH2O, for PImax and PEmax, respectively). The decrease in PEmax was significantly correlated with the severity of bronchial obstruction as evaluated based on baseline FEV1 (% predicted). Forced expiratory flows did not change after either CPT session. The amount of sputum expectorated was similar for the two CPT sessions (5.3 +/- 5.3 g vs 4.6 +/- 4.8 g after the control and PSV session, respectively; NS). Fifteen patients felt less tired after the PSV session. Ten patients reported that expectoration was easier with PSV, whereas 4 did not note any difference; 2 patients did not expectorate. Nine patients expressed a marked and 5 a small preference for PSV, and 2 patients had no preference. The physiotherapists found it easier to perform CPT with PSV in 14 patients and did not perceive any difference in 2 patients.

DISCUSSION

Our study in CF children shows that respiratory muscle performance, as evaluated based on various parameters, decreased after CPT and that significant falls in oxygen saturation occurred after the FET maneuvers despite the quiet breathing periods between each FET cycle. These unwanted effects of CPT were

摘要

目的

胸部物理治疗(CPT)是囊性纤维化(CF)患者治疗的一个组成部分。CPT会增加额外的呼吸功,这可能带来呼吸肌疲劳的风险。吸气压力支持通气(PSV)是一种新的通气辅助模式,旨在在自主吸气期间维持恒定的预设气道正压,其目的是减少患者的吸气功。我们研究的目的是:1)评估CPT期间的呼吸肌疲劳和氧饱和度下降情况;2)确定无创PSV是否可以缓解CPT的这些潜在不良反应。

方法

16名病情稳定、平均年龄为13±4岁的CF患者参与了本研究。对于CPT,我们采用了用力呼气技术(FET),它包括一个或多个从接近肺总量(TLC)开始、在接近残气量结束的缓慢主动呼气。每次呼气后,要求患儿进行一次缓慢、非最大程度的膈肌吸气。在进行一到四个用力呼吸周期后,要求患儿咳嗽并咳痰。一次典型的20分钟CPT治疗包括10至15次FET动作,每次动作之间间隔10至20个呼吸周期的休息时间。在研究过程中,每位患者在两天的同一时间、由同一名物理治疗师以随机顺序接受两次CPT治疗。在这两次治疗中的一次期间,通过使用专为急性患者设计的压力支持发生器ARM25(TAEMA,法国安东尼)经鼻面罩在整个治疗过程中提供PSV(PSV治疗)。对照治疗在不使用鼻面罩或PSV的情况下进行。两次CPT治疗均在不补充氧气的情况下进行。在每次CPT治疗前后记录肺功能、最大吸气压力(PImax)和呼气压力(PEmax)。

结果

PSV治疗和对照治疗前的平均肺功能参数具有可比性。基线脉搏血氧饱和度(SpO2)与基线肺活量(预测值百分比)和第1秒用力呼气量(FEV1)(预测值百分比)显著相关。PSV与潮气量(Vt)从0.42±0.01升增加到1.0±0.02升有关。PSV期间呼吸频率显著降低。与对照治疗相比,PSV期间FET动作之间的SpO2显著更高。对照治疗期间FET后SpO2的下降(最低点:91.8±0.7%)比PSV治疗期间(93.8±0.6%)显著更大。对照治疗期间最大压力下降(PImax和PEmax分别从71.9±6.1降至60.9±5.3 cmH2O,从85.3±7.9降至77.5±4.8 cmH2O),而PSV治疗期间最大压力增加(PImax和PEmax分别从71.6±8.6升至83.9±8.7 cmH2O,从80.4±7.8升至88.0±7.4 cmH2O)。基于基线FEV1(预测值百分比)评估,PEmax的下降与支气管阻塞的严重程度显著相关。两次CPT治疗后用力呼气流量均未改变。两次CPT治疗咳出的痰量相似(对照治疗和PSV治疗后分别为5.3±5.3克和4.6±4.8克;无显著性差异)。15名患者在PSV治疗后感觉疲劳减轻。10名患者报告使用PSV咳痰更容易,而4名患者未注意到任何差异;2名患者未咳痰。9名患者对PSV表现出明显偏好,5名患者有轻微偏好,2名患者无偏好。物理治疗师发现,14名患者在使用PSV时进行CPT更容易,2名患者未感觉到有任何差异。

讨论

我们对CF儿童的研究表明,基于各种参数评估,CPT后呼吸肌功能下降,并且尽管每个FET周期之间有安静呼吸期,但FET动作后氧饱和度仍显著下降。CPT的这些不良影响是……

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验